Back to Search
FRED VALENTINE, M.D.
M.D.
Specialist
NPI: 1942359815Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
095931(NY)
Research & Publications (20)
Implementation of HIV testing at 2 New York City bathhouses: from pilot to clinical service.
PMID 19400690·Clin Infect Dis·2009
8-other
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.
PMID 18171293·J Infect Dis·2008
4-observational
A reverse transcriptase assay for early diagnosis of infant HIV infection in resource-limited settings.
PMID 17562687·J Trop Pediatr·2007
8-other
Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus.
PMID 17357051·J Infect Dis·2007
4-observational
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
PMID 16897665·J Infect Dis·2006
8-other
Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings.
PMID 16081912·J Clin Microbiol·2005
8-other
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.
PMID 15597521·AIDS Res Hum Retroviruses·2004
3-trial
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
PMID 15097300·J Acquir Immune Defic Syndr·2004
3-trial
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
PMID 14673757·J Infect Dis·2003
3-trial
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.
PMID 14518696·Antivir Ther·2003
3-trial
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.
PMID 12646792·AIDS·2003
3-trial
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.
PMID 12167274·AIDS Res Hum Retroviruses·2002
3-trial
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
PMID 12095381·JAMA·2002
3-trial
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.
PMID 11865394·J Infect Dis·2002
8-other
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
PMID 11294662·J Infect Dis·2001
8-other
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
PMID 10877738·Ann Intern Med·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE, DEPARTMENT OF MEDICINE
NEW YORK, NY 10016 - Phone
- (212) 263-6401
Quick Facts
- NPI
- 1942359815
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile